H23805
4-ヒドロキシクマリン
98%
別名:
4-ヒドロキシ-1-ベンゾピラン-2-オン
ログインで組織・契約価格をご覧ください。
サイズを選択してください
表示を変更する
この商品について
実験式（ヒル表記法）:
C9H6O3
CAS番号:
分子量:
162.14
UNSPSC Code:
12352100
NACRES:
NA.22
PubChem Substance ID:
EC Number:
214-060-2
Beilstein/REAXYS Number:
129768
MDL number:
Assay:
98%
Quality Level
assay
98%
mp
211-213 °C (lit.)
fluorescence
λem 373 nm in methanol
SMILES string
OC1=CC(=O)Oc2ccccc12
InChI
1S/C9H6O3/c10-7-5-9(11)12-8-4-2-1-3-6(7)8/h1-5,10H
InChI key
VXIXUWQIVKSKSA-UHFFFAOYSA-N
Gene Information
mouse ... Maoa(17161)
rat ... Aldh1a2(116676)
Still not finding the right product?
Explore all of our products under 4-ヒドロキシクマリン
signalword
Warning
hcodes
Hazard Classifications
Acute Tox. 4 Oral
保管分類
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
dust mask type N95 (US), Eyeshields, Gloves
適用法令
試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。
H23805-100G: + H23805-VAR: + H23805-5G: + H23805-BULK: + H23805-500G:
jan
Benye Liu et al.
Plant molecular biology, 72(1-2), 17-25 (2009-09-17)
Coumarin forms in melilotoside (trans-ortho-coumaric acid glucoside)-containing plant species upon cell damage. In moldy melilotoside-containing plant material, trans-ortho-coumaric acid is converted by fungi to 4-hydroxycoumarin, two molecules of which spontaneously combine with formaldehyde to give dicoumarol. Dicoumarol causes internal bleeding
Davorka Završnik et al.
Molecules (Basel, Switzerland), 16(7), 6023-6040 (2011-07-21)
We report on the synthesis of 4-hydroxycoumarin dimers 1-15 bearing an aryl substituent on the central linker and fused benzopyranocoumarin derivatives 16-20 and on their in vitro broad anti-DNA and RNA virus activity evaluations. The chemical identities and structure of
Dharmesh H Mahajan et al.
Archiv der Pharmazie, 342(5), 281-290 (2009-05-06)
Novel 2-(coumarin-4-yloxy)-4,6-(substituted)-s-triazine derivatives i. e., diaryltriazine (DATA) are reported as novel non-nucleoside reverse transcriptase inhibitors (NNRTIs), were synthesized and their activities against human immunodeficiency virus HIV-1 (III-B), HIV-2 (ROD), and the double RT mutant HIV-1 (K103N and Y181C) were assessed.